Table 2

IMVD and postoperative survival according to the status of combination of Ang-1 and Ang-2 expression

Ang-1(−)/Ang-2(−) (n = 122)Ang-1(−)/Ang-2(+) (n = 13)Ang-1(+)/Ang-2(−) (n = 74)Ang-1(+)/Ang-2(+) (n = 27)
IMVD (mean± SE)
 CD34-IMVDa176.7 ± 9.1203.7 ± 25.2177.5 ± 11.3188.0 ± 19.2
 CD105-IMVDb35.3 ± 4.0c51.9 ± 22.643.9 ± 12.1d59.0 ± 10.4
5-yr survival rate69.2%66.7%72.0%45.9%e
  • a IMVD determined with an anti-CD34 mAb.

  • b IMVD determined with an anti-CD105 mAb.

  • c P < 0.05 for Ang-1(−)/Ang-2(−) versus Ang-1(−)/Ang-2(+), versus Ang-1(+)/Ang-2(+).

  • d P < 0.05 for Ang-1(+)/Ang-2(−) versus Ang-1(+)/Ang-2(+).

  • e P < 0.05 for Ang-1(+)/Ang-2(+) versus any other group.